CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy CEO, President, and Secretary bought 200,000 shares at an average $0.68 ($135,575)
- 4 Open-market buy General Counsel bought 20,000 shares at $0.64 ($12,858)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
- 4 Open-market buy CFO and Treasurer bought 15,000 shares at $0.77 ($11,489)
- 4 Open-market buy Chief Scientist bought 13,500 shares at an average $0.73 ($9,885)
- 8-K Event Delisting notice
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 3 of 17 · 328 filings